Show simple item record

dc.contributor.authorCarter, Jane
dc.date.accessioned2025-11-18T06:58:06Z
dc.date.available2025-11-18T06:58:06Z
dc.date.issued2022-06-28
dc.identifier.citationFrancois Kiemde, Halidou Tinto, Jane Carter, Toussaint Rouamba, Daniel Valia, Lesong Conteh, Elisa Sicuri, Bryony Simmons, Bakri Nour, Davis Mumbengegwi, Asrat Hailu, Stephen Munene, Albadawi Talha, Mulugeta Aemero, Paul Meakin, René Paulussen, Scott Page, Norbert van Dijk, Petra Mens, Henk Schallig. Phase 3 evaluation of an innovative simple molecular test for the diagnosis of malaria in different endemic and health settings in sub-Saharan Africa (DIAGMAL). PLOS ONE. 2022; 17 (9):e0272847.en_US
dc.identifier.urihttps://repository.amref.ac.ke/handle/20.500.14173/1094
dc.description.sponsorshipFunding: European & Developing Countries Clinical Trials Partnership as part of the EDCTP2 programme supported by the European Union (grant number RIA2018D-2496-DIAGMAL -HDFHS coordinator). FK is a recipient of a Career Developing Fellowship (CDF) from EDCTP (TMA2019CDF-2697). The funder had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.en_US
dc.language.isoenen_US
dc.publisherPLOS One - Research journalsen_US
dc.subjectMalaria Diagnosis, Sub-Saharan Africaen_US
dc.titlePhase 3 evaluation of an innovative simple molecular test for the diagnosis of malaria in different endemic and health settings in sub-Saharan Africa (DIAGMAL)en_US
dc.typeArticle, Journalen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record